Pulmonary Health

Valuable Information On Pulmonary Health For You To Battle COPD, Emphyzema and Other Pulmonary Diseases

May is American Stroke Month

Filed under: Pulmonary Health — What's New on MedlinePlus at 10:00 pm on Wednesday, April 30, 2008

May is American Stroke Month. Check out the MedlinePlus stroke topic page, which includes interactive tutorials on stroke prevention and stroke rehabilitation . Also, learn more by reading the latest news.


Live Webcast: Total Knee Replacement

Filed under: Pulmonary Health — What's New on MedlinePlus at 10:00 pm on Wednesday, April 30, 2008

Watch a live webcast of a total knee replacement surgery on May 2 at 12 p.m. EDT.

Also, browse through links to prerecorded webcasts of surgical procedures. These are actual procedures performed at medical centers in the United States.


Glaxo: FDA OKs Advair 250/50 to reduce exacerbations in COPD patients – Interactive Investor

Filed under: COPD - Chronic Obstructive Pulmonary Disease,Pulmonary Health — COPD - Google News at 4:42 pm on Wednesday, April 30, 2008

Glaxo: FDA OKs Advair 250/50 to reduce exacerbations in COPD patients
Interactive Investor, UK - Apr 30, 2008
COPD is a progressive, life-threatening lung disease that includes chronic bronchitis, emphysema or both. With this approval, Advair becomes the only ...

GSK Says FDA Approved Advair 250/50 For Reduction Of Exacerbations … – RTT News

Filed under: COPD - Chronic Obstructive Pulmonary Disease,Pulmonary Health — COPD - Google News at 3:49 pm on Wednesday, April 30, 2008

GSK Says FDA Approved Advair 250/50 For Reduction Of Exacerbations ...
RTT News, NY - 11 minutes ago
... inhalation powder) for the reduction of exacerbations in patients with chronic obstructive pulmonary disease (COPD) who have a history of exacerbations. ...

FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in … – SunHerald.com

Filed under: COPD - Chronic Obstructive Pulmonary Disease,Pulmonary Health — COPD - Google News at 3:45 pm on Wednesday, April 30, 2008

FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in ...
SunHerald.com, MS - 15 minutes ago
With this approval, Advair becomes the only treatment FDA has approved to reduce COPD exacerbations. Treatment guidelines for COPD state that the reduction ...

Glaxo wins US FDA approval for wider Advair use – Reuters

Filed under: COPD - Chronic Obstructive Pulmonary Disease,Pulmonary Health — COPD - Google News at 3:21 pm on Wednesday, April 30, 2008

Glaxo wins US FDA approval for wider Advair use
Reuters - 39 minutes ago
N: Quote, Profile, Research) Advair is safe and effective to more widely treat patients with chronic obstructive pulmonary disease (COPD), the drugmaker ...

The Safety of ECT in Patients With Chronic Obstructive Pulmonary … – Psychosomatics (subscription)

Filed under: COPD - Chronic Obstructive Pulmonary Disease,Pulmonary Health — COPD - Google News at 11:21 am on Wednesday, April 30, 2008

The Safety of ECT in Patients With Chronic Obstructive Pulmonary ...
Psychosomatics (subscription) - Apr 30, 2008
Very little has been written about the safety and management strategy of ECT patients with chronic obstructive pulmonary disease (COPD). ...

The Safety of ECT in Patients With Chronic Obstructive Pulmonary … – Psychosomatics (subscription)

Filed under: COPD - Chronic Obstructive Pulmonary Disease,Pulmonary Health — COPD - Google News at 11:21 am on Wednesday, April 30, 2008

The Safety of ECT in Patients With Chronic Obstructive Pulmonary ...
Psychosomatics (subscription) - 4 hours ago
Very little has been written about the safety and management strategy of ECT patients with chronic obstructive pulmonary disease (COPD). ...

SOURCE: St. Luke's – Roosevelt Hospital Center – Market Wire (press release)

Filed under: COPD - Chronic Obstructive Pulmonary Disease,Pulmonary Health — COPD - Google News at 9:53 am on Wednesday, April 30, 2008

SOURCE: St. Luke's - Roosevelt Hospital Center
Market Wire (press release) - Apr 30, 2008
"Alpha-1 is the most significant genetic risk factor for COPD (chronic obstructive pulmonary disease), which the fourth leading cause of death in America ...

SOURCE: St. Luke's – Roosevelt Hospital Center – Market Wire (press release)

Filed under: COPD - Chronic Obstructive Pulmonary Disease,Pulmonary Health — COPD - Google News at 9:53 am on Wednesday, April 30, 2008

SOURCE: St. Luke's - Roosevelt Hospital Center
Market Wire (press release) - 6 hours ago
"Alpha-1 is the most significant genetic risk factor for COPD (chronic obstructive pulmonary disease), which the fourth leading cause of death in America ...
Next Page »